Newsbenzinga
REGENXBIO Says All Ongoing Patent Litigation Regarding Patents-In-Suit To Be Terminated With Prejudice; Agrees Not To Sue Sarepta Or Affiliates Over Existing Elevidys Or AAVrh74-Based Capsids
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…